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Abstract Peptidoglycan (PG) is an essential component of
the bacterial cell envelope. This macromolecule consists of
glycan chains alternating N-acetylglucosamine and N-
acetylmuramic acid, cross-linked by short peptides containing
nonstandard amino acids. Structural analysis of PG usually
involves enzymatic digestion of glycan strands and separation
of disaccharide peptides by reversed-phase HPLC followed
by collection of individual peaks for MALDI-TOF and/or tan-
demmass spectrometry. Here, we report a novel strategy using
shotgun proteomics techniques for a systematic and unbiased
structural analysis of PG using high-resolution mass spec-
trometry and automated analysis of HCD and ETD fragmen-
tation spectra with the Byonic software. Using the PG of the
nosocomial pathogen Clostridium difficile as a proof of con-
cept, we show that this high-throughput approach allows the
identification of all PG monomers and dimers previously de-
scribed, leaving only disambiguation of 3–3 and 4–3 cross-
linking as a manual step. Our analysis confirms previous find-
ings that C. difficile peptidoglycans include mainly
deacetylated N-acetylglucosamine residues and 3–3 cross-
links. The analysis also revealed a number of low abundance
muropeptides with peptide sequences not previously reported.
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Introduction
The major and essential polymer within the bacterial cell en-
velope is peptidoglycan (PG), which forms a single bag-
shaped macromolecule (or sacculus) around the cell [1]. PG
is unique to the bacterial kingdom, and its synthesis is the
target of the most clinically important antibiotics ever discov-
ered such as the beta-lactams (penicillin) and glycopeptides
(vancomycin). In addition to a role as an exoskeleton that
confers cell shape and resistance to the intracellular osmotic
pressure, PG is used as a scaffold for the display of a myriad of
polymers and proteins at the cell surface.
PG composition is variable amongst the bacteria, but is usu-
ally highly conserved within a given species [2]. The macromol-
ecule is made of beta-1,4-linked glycan chains alternating N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid
(MurNAc). MurNAc residues are substituted via a lactyl group
by pentapeptide stems most frequently made of L-Ala-iso-D-Glu-
meso-DAP (or L-Lys)-D-Ala-D-Ala (mDAP, meso-
diaminopimelic acid). During growth, PG precursors are assem-
bled in the cytoplasm and translocated at the cell surface where
they are polymerized. Whilst glycan chain polymerization is
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conserved, two types of enzymes can cross-link peptide stems
(Fig. 1). D,D-Transpeptidases recognize the C-terminal D-Ala-D-
Ala extremity of a donor stem. They form a covalent intermedi-
ate with the D-Ala in position 4 and link the COOH group of this
residue to theNH2 group of themDAP residue in position 3 of an
acceptor peptide stem, thereby forming 4–3 cross-links. D,D-
Transpeptidases are also called penicillin-binding proteins
(PBPs) as they are inhibited irreversibly by beta-lactam antibi-
otics, which are D-Ala-D-Ala structural analogs. Peptidoglycan
cross-links can also result from the activity of L,D-
transpeptidases. These enzymes recognize the last two residues
of a tetrapeptide donor stem substrate generated by a carboxy-
peptidase. They form a covalent intermediate with the meso-
DAP in position 3 and link the COOH group of this residue to
the NH2 group of the mDAP of an acceptor peptide stem. L,D-
Transpeptidases form 3–3 cross-links and are not inhibited by
beta-lactam antibiotics. In addition to distinct modes of polymer-
ization, several enzymatic modifications take place during
growth, a process called BPG remodeling.^ Such modifications
can occur on glycan strands (e.g.,O-acetylation or de-N-acetyla-
tion), reviewed by Vollmer [3], or on peptide stems (e.g.,
amidation of γD-Glu, cleavage of C-terminal residues, or amino
acid substitutions mediated by L,D-transpeptidases), reviewed by
Vollmer et al. [1].
Surprisingly, the strategy proposed nearly 30 years ago by
Bernd Glauner [4] is still used routinely to explore PG structure.
It involves the purification of PG sacculi, followed by digestion
with lysozyme to generate disaccharide peptides (muropeptides)
that are separated by reversed-phase HPLC. Individual fractions
are collected, desalted and analysed by MS and MS/MS.
Improvement of chromatography equipment has increased the
throughput of PG analyses, allowing the separation of several
micrograms of muropeptides in less than 30 min [5, 6]. Recent
studies have reported PG structural analysis using online LC-
ESI-MS [7] or LC-ESI-MS/MS [8–10] for the identification of
muropeptides. Although these approaches overcome a major
limitation (time-consuming offline fractionation), they still rely
on manual analysis of the major ions and, hence, have limited
capability to search for new PG components, likely biasing the
analysis towards previously identified species. To the best of our
knowledge, no automated analysis of peptidoglycan tandem
mass spectra has been reported before.
Here, we describe a novel strategy for a systematic, unbiased,
structural analysis of PG that combines high mass accuracy and
automated analysis of HCD and ETD fragmentation spectra
using Byonic and Byologic software (Protein Metrics, San
Carlos, CA). Using the PG of the nosocomial pathogen
Clostridium difficile as a proof of concept, we show that this
Fig. 1 Composition and polymerization of bacterial peptidoglycan (PG). PG
building blocks, cut from larger PG chains with mutanolysin cleavages
indicated by (M), correspond to the disaccharide-pentapeptide GlcN-
MurNAc-L-Ala-iD-Glu-mDAP-D-Ala-D-Ala. PG components can be cross-
linked by two distinct mechanisms: (a) D,D-transpeptidation results in the
formation of a 4–3 bond between a donor and an acceptor stem; (b) L,D-
transpeptidation follows cleavage of D-Ala in position 5 and results in the
formation of a 3–3 bond between a donor and an acceptor stem
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systematic, unbiased, Bbottom up^ approach allows the identifi-
cation and quantitation of all PG monomers and dimers previ-
ously described, leaving only disambiguation of 3–3 and 4–3
cross-linking as a manual step. Our analysis confirms previous
findings [11] that C. difficile peptidoglycans include mainly
deacetylated GlcNAc residues (GlcN) and 3–3 cross-links, and
that acceptor peptides often include glycine substituted for the D-
Ala in position 4. Byonic’s Bwildcard^ search, which allows any
mass delta on any one residue, also finds a number of low abun-
dance muropeptides with peptide sequences not previously re-
ported. Variable residues are located at the C-terminus of accep-
tor peptides, after the mDAP in position 3.
Experimental section
Extraction and purification of peptidoglycan samples
Fifty milliliters of TY broth was inoculated with an overnight
culture of C. difficile strain 630 [11] at a starting OD600 of
0.05. Exponentially growing cells (OD600 = 0.45) were col-
lected by centrifugation at 4500 rpm for 10 min at 25 °C. The
pellet was resuspended in 10 mL of boiling MilliQ water
(MQ) before the addition of an equal volume of boiling SDS
8%.After 30min at 100 °C, the cells were left to cool down to
room temperature. Insoluble cell walls were pelleted at
45,000g for 15 min and washed five times using 30 mL of
MilliQ water. Proteins covalently bound to peptidoglycan
were removed by pronase treatment (final concentration of
2 mg/mL for 4 h at 60 °C). Protease-treated cell walls were
washed 6 times with 30 mL of MilliQ water before covalently
bound polymers were removed by incubation in 1 M HCl for
5 h at 37 °C. Insoluble pure peptidoglycan was washed 6 times
with MilliQ water, freeze-dried and resuspended at a final
concentration of 10 mg/mL.
Preparation of soluble muropeptides
One milligram of purified peptidoglycan (HCl-treated cell
walls) were digested overnight in 50 mM phosphate buffer
(pH 5.5) supplemented with 100 μg of mutanolysin in a final
volume of 125 μL. Following heat inactivation of
mutanolysin (5 min at 100 °C), soluble disaccharide peptides
were then mixed with an equal volume of 250 mM borate
buffer (pH 9.25) and reduced with 1 % (m/v) sodium borohy-
dride. After 20 min at room temperature, the pH was adjusted
to 4.5 using phosphoric acid. Reduced muropeptides were
desalted by rp-HPLC using water–formic acid 0.1 % (v/v) as
buffer A and one-step elution with 25 % acetonitrile (v/v)–
formic acid 0.1 % (v/v) gradient.
Data acquisition Samples were analysed online using an
UltiMate 3000 RSLCnano LC System (Dionex) coupled to
an LTQ Orbitrap Elite hybrid mass spectrometer (Thermo)
equipped with a nanospray ion source. Desalted muropeptides
(300 ng) were separated on a PicoFritTM Hypersil Gold aQ
analytical column (1.9 μm, 75 μm id × 50 cm,) (New
Objective). Muropeptides were eluted for 10 min with water +
0.1 % (v/v) formic acid + 0.8 % (v/v) acetonitrile (buffer A)
and then with a 50-min acetonitrile linear gradient (0 to
22.5 %) in buffer A at a flow rate of 0.3 μl/min. The mass
spectrometer was operated in standard data-dependent acqui-
sition mode controlled by Xcalibur 2.2. The instrument was
operated with a cycle of oneMS (in the Orbitrap) acquired at a
resolution of 120,000 atm/z 400 from 150 to 2000m/z and the
top 5 most abundant multiply charged (2+ and higher) ions in
a given chromatographic window were subjected to either
HCD fragmentation (isolation window 3m/z, normalized col-
lision energy = 25, activation time 10 ms) or ETD fragmenta-
tion (isolation window 3m/z, normalized collision energy =
35, activation time 300 ms) in the linear ion trap with supple-
mental activation enabled. An FTMS target value of 1e6, an
HCD target value of 50,000 and an ion trap MSn target value
of 10,000 were used. Dynamic exclusion was enabled with a
repeat duration of 30 s with an exclusion list of 500 and ex-
clusion duration of 30 s. Lock mass of 445.120025 was en-
abled for all experiments.
Data analysisWe used Byonic version 2.8.0 to identify pep-
tidoglycan forms, Byologic version 2.4.21 to compute extract-
ed ion chromatograms (XICs) and relative abundances, and
Byomap 2.4.21 to view and annotate peaks in the total ion
chromatogram (TIC). We started by searching for PG mono-
mers using a FASTA database containing only the peptide
sequences AEM, AEMA and AEMG. We specified a fixed
modification of +41.0443 on methionine (M) so that modified
M represented mDAP with mass 172.0848 (=131.0405 +
41.0443). We enabled variable modifications of 277.116
(MurNAc), 396.174 (GlcN-deacetyl-MurNAc), 420.174
(GlcN-anhydro-MurNAc), 438.185 (GlcN-MurNAc) and
480.196 (GlcNAc-MurNAc) on the peptide N-terminus. We
also enabled variable modifications of –0.984 (amidation) on
E andmDAP. In a subsequent search, we turned off amidation,
anhydro and deacetylation and used a wildcard modification
of mass –130 to +210 Da to find unanticipated modifications
and sequence variants. All searches after some initial explor-
atory searches used a BManual score cut^ of zero, 5 ppm pre-
cursor mass tolerance, 20 ppm fragment mass tolerance for
HCD spectra and 0.5 Da fragment mass tolerance for ETD
spectra.
We searched for PG dimers two different ways: cross-link
search on a monomer database and Bordinary^ search on a
dimer database. Byonic includes automatic cross-link search
with user-defined cross-link mass and residue specificity, but
with the limitation that the cross-link connects two residues of
the same type. We specified −18.0106 as the cross-link mass
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and M (meaning mDAP) as the residue type. We ran Byonic
on a FASTA database of monomer sequences and enabled the
glycans GlcN-MurNAc and GlcNAc-MurNAc on the N-ter-
minus. Byonic then predicts the correct b/y (or c/z) ions for 3–
3 linkages from Glycan-A-E-mDAP to any Glycan-A-E-
mDAP-X (or –X-X) peptide, but slightly incorrect b/y (or
c/z) ions for 4–3 linkages from Glycan-A-E-mDAP-A to
Glycan-A-E-mDAP-X peptides, because it fails to predict
the b-ion containing Glycan-A-E-mDAP and the complemen-
tary y-ion containing A and Glycan-A-E-mDAP-X. We also
searched for dimers using a FASTA database containing
concatenated sequences such as AEMAEMA and allowing
Table 1 List of detected monomers with peptides (m =mDAP), glycans, precursor masses, apex elution times, XIC integrals and percent of reported
XIC integrals
Peptide Charges Glycan Neutral Mass 
(Daltons) 
Elution
Time 
(Minutes)
XIC Integral    
(Ion Counts)
% of XICs
Sum=29.2%
AEmA 2 GlcN-MurNAc 899.3971 9.97 3.81E+10 22.35%
2 MurNAc 738.3283 9.89 4.78E+08 0.28%
1 (none) 461.2122 9.89 2.82E+07 0.02%
AEmG 2 GlcN-MurNAc 885.3815 9.12 3.28E+09 1.92%
2 MurNAc 724.3126 8.94 3.93E+07 0.02%
AEmF 2 GlcN-MurNAc 975.4284 37.37 1.41E+09
0.83%
2 MurNAc 814.3596 37.37 1.42E+07
0.01%
AEm 2 GlcN-MurNAc 828.3600 8.66 1.13E+09
0.66%
AEmA 2 GlcNAc-MurNAc 941.4077 13.25 1.11E+09
0.65%
AEm(I/L) 2 GlcN-MurNAc 941.4441 32.67 8.76E+08
0.51%
1 MurNAc 780.3752 32.67 1.46E+08
0.09%
AEmV 2 GlcN-MurNAc 927.4284 27.26 7.55E+08
0.44%
AEmS 2 GlcN-MurNAc 915.3920 8.75 5.53E+08
0.32%
AEmY 2 GlcN-MurNAc 991.4233 30.25 3.28E+08
0.19%
AEm(NH2)A 2 GlcN-MurNAc 898.4131 9.37 2.08E+08
0.12%
AEmM 2 GlcN-MurNAc 959.4005 27.11 1.94E+08
0.11%
AEmR 2, 3 GlcN-MurNAc 984.4611 8.66 1.71E+08
0.10%
2 MurNAc 823.3923 8.75 7.77E+07
0.05%
AEmAA
2
GlcN-MurNAc 970.4342 14.45 1.23E+08 0.07%
AEm(NH2) 2 GlcNAc-MurNAc 869.3905 9.37 1.02E+08
0.06%
AEmGG 2 GlcN-MurNAc 942.4029 8.48 9.53E+07
0.06%
AEm[A-V]
2
GlcN-MurNAc 998.4655 33.92 9.12E+07 0.05%
AEmK 2 GlcN-MurNAc 956.4550 6.85 8.03E+07
0.05%
2
MurNAc 795.3861 8.37 2.38E+07 0.01%
AEm[A-G] 2 GlcN-MurNAc 956.4186 11.37 7.77E+07
0.05%
AEmH
2, 3
GlcN-MurNAc 965.4189 8.64 7.17E+07 0.04%
AEmGV
2
GlcN-MurNAc 984.4499 27.26 6.93E+07 0.04%
AEm
2
GlcN-anh-MurNAc 810.3494 10.15 4.40E+07 0.03%
AEmF
2
GlcNAc-MurNAc 1017.4390 40.97 3.29E+07 0.02%
AEm(I/L)
2
GlcNAc-MurNAc 983.4546 36.40 1.66E+07 0.01%
AEmASV
2
GlcN-MurNAc 1085.4975 29.04 1.56E+07 0.01%
The XIC integral is the ion count for the monoisotopic precursor, summed over charge states for the monomers observed in more than one charge state,
that is, AEmR andAEmH. Rows with peptides left blank showmonomers formed in the electrospray source by loss of monosaccharides, recognizable as
in-source decay by exact co-elution. Shaded rows show monomers with the most common glycan (GlcN-MurNAc). Brackets as in [A-G] indicate
uncertain order of the amino acid residues; (I/L) indicates either isoleucine or leucine. 77.6 % of all monomers are GlcN-MurNAc-AEmA. Of the peptide
sequence variants, only AEmG has been reported before
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glycan modifications on both N- and C-termini; this method
predicts the correct ions for cleavages of peptide bonds up to
the cross-link, that is, correct b1, b2, b3 and y6, y5, y4 for the
3–3 link, but incorrect ions for cleavages after the cross-link.
Incorrect ion predictions adversely affect Byonic scores, and
this is one of the reasons that we used a manual score cutoff of
zero (the other reason is that the usual methods for creating
decoy databases, for example, reversing peptide sequences, do
not work well for PG analysis, in which accurate precursor
mass may be more informative than fragmentation peaks,
many of which are common to multiple scored candidates).
Byonic does not currently offer cross-link search for
more than two linked peptides, so we searched for trimers
using a FASTA database containing sequences such as
AEMAEMAEMA and allowing glycan modifications on
N- and C-termini as well as on M. As above, this method
predicts correct ions for cleavages up to the first cross-link
but incorrect ions after that. When searching for dimers and
trimers, we did not search for all possible combinations of
monomers, but limited attention to those in which all donor
peptides are either AEM or AEMA, that is, the peptides
acted upon by the L,D and D,D transpeptidases. We tried all
the monomers we discovered in the monomer searches as
the terminal acceptor peptide for dimers and trimers.
Byologic and Byomap offer complementary ways to view
and quantify peptides, byXIC and TIC or UV trace, respectively.
Table 2 List of most abundant dimers with peptides (m =mDAP), glycans, masses, apex elution times and abundances
Peptides Charges Glycans Neutral
Mass 
Elution 
Time 
XIC 
Integral    
% of XICs
Sum=57.4%
AEm, AEmA 2, 3 GlcN-MurNAc,  GlcN-MurNAc 1709.747 28.47 4.18E+10 24.52%
2, 3 GlcN-MurNAc,  MurNAc 1548.678 28.47 9.43E+09 5.53%
2 MurNAc, MurNAc 1387.609 28.47 1.28E+09 0.75%
AEmA, AEmA 2, 3 GlcN-MurNAc,  GlcN-MurNAc 1780.784 30.49 1.23E+10 7.21%
2, 3 GlcN-MurNAc,-MurNAc 1619.715 30.41 1.77E+09 1.04%
2 MurNAc, MurNAc 1458.646 30.41 2.47E+08 0.14%
AEm, AEmG 2, 3 GlcN-MurNAc, GlcN-MurNAc 1695.731 27.11 6.74E+09 3.95%
2, 3 GlcN-MurNAc, MurNAc 1534.662 27.11 1.66E+09 0.97%
2 MurNAc, MurNAc 1373.593 27.11 2.92E+08 0.17%
AEm, AEmA 2, 3 GlcN-MurNAc, GlcNAc-MurNAc 1751.757 31.39 4.84E+09 2.84%
AEm, AEmA 2, 3 GlcN-MurNAc 1271.562 21.17 3.34E+09 1.96%
2 MurNAc 1110.493 21.17 1.51E+09 0.89%
AEm, AEm 2, 3 GlcN-MurNAc, GlcN-MurNAc 1638.709 27.85 2.46E+09 1.44%
2 GlcN-MurNAc, MurNAc 1477.641 27.85 7.17E+08 0.42%
AEmA, AEmA 2, 3 GlcN-MurNAc, GlcNAc-MurNAc 1822.794 32.98 1.74E+09 1.02%
AEmA, AEmG 2, 3 GlcN-MurNAc, GlcN-MurNAc 1766.768 28.24 1.57E+09 0.92%
AEm, AEmF 2, 3 GlcN-MurNAc, GlcN-MurNAc 1785.778 43.84 9.47E+08 0.56%
2, 3 GlcN-MurNAc, MurNAc 1624.709 43.84 2.03E+08 0.12%
AEmA, AEmA 2, 3 GlcN-MurNAc 1342.599 24.70 8.42E+08 0.49%
2 MurNAc 1181.530 24.79 3.01E+08 0.18%
AEm, AEmG 2, 3 GlcN-MurNAc 1257.546 11.98 6.06E+08 0.36%
AEm, AEm(I/L) 2, 3 GlcN-MurNAc, GlcN-MurNAc 1751.794 41.05 5.20E+08 0.31%
AEm, AEmY 2, 3 GlcN-MurNAc, GlcN-MurNAc 1801.773 38.02 4.87E+08 0.29%
AEm, AEmV 2, 3 GlcN-MurNAc, GlcN-MurNAc 1737.778 36.71 3.38E+08 0.20%
AEm, AEmR 2, 3, 4 GlcN-MurNAc, GlcN-MurNAc 1794.811 26.71 3.21E+08 0.19%
AEm, AEmG 2 GlcN-MurNAc, GlcNAc-MurNAc 1737.741 29.04 3.16E+08 0.19%
AEmA, AEmF 2, 3 GlcN-MurNAc, GlcN-MurNAc 1856.815 45.10 2.52E+08 0.15%
AEm, AEmK 2, 3, 4 GlcN-MurNAc, GlcN-MurNAc 1766.804 25.52 2.46E+08 0.14%
AEm, AEm 2 GlcN-MurNAc, GlcNAc-MurNAc 1680.720 29.70 2.41E+08 0.14%
AEm, AEmGG 2, 3 GlcN-MurNAc, GlcN-MurNAc 1752.752 26.63 2.37E+08 0.14%
AEm, AEm 2, 3 GlcN-MurNAc 1200.525 13.25 2.34E+08 0.14%
AEmA, AEmV 2, 3 GlcN-MurNAc, GlcN-MurNAc 1808.815 40.47 1.19E+08 0.07%
Shaded rows show dimers with the most common donor peptide (AEm) and glycans (GlcN-MurNAc); acceptor peptide prevalences (AEmA, AEmG,
AEm, AEmF, etc.) agree well with monomer abundances. About 54 % of the dimers correspond to GlcN-MurNAc-AEm donors cross-linked to GlcN-
MurNAc-AEmA acceptors via a 3–3 bond
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We used Byologic to validate and quantify PG forms identified
by Byonic and Byomap to obtain a TIC trace, inspect MS full
scans and map PG forms to TIC elution peaks. We used manual
analysis to distinguish 3–3 from 4–3 linkages for the dimers
containing one Glycan-A-E-mDAP and one Glycan-A-E-
mDAP-A or twoGlycan-A-E-mDAP-A’s, which is isobaric with
a Glycan-A-E-mDAP and Glycan-A-E-mDAP-A-A dimer.
Results and discussion
As shown in Tables 1, 2 and 3, the Byonic searches found 29.2,
57.4 and 13.4 %monomers, dimers and trimers, as percentages
of the total of identified XIC quantities. These proportions are
consistent with the percentages of 35.1, 56.6 and 8.3 % report-
ed previously [11] based on UV traces quantifications and
MALDI-TOF offline analyses rather than LC-ESI quantitation.
We find that 77.6 % of monomers are GlcN-MurNAc-AEmA
(here m =mDAP), in close agreement with 74.9 % from Peltier
et al. These monomers containing tetrapeptide stems result
from carboxypeptidase activity (see Electronic Supplementary
Material (ESM) Fig. S2). GlcN-MurNAc-AEm is not the most
common monomer because it is usually linked rather than free.
We find that 42.7%of dimers areGlcN-MurNAc-AEm linked to
GlcN-MurNAc-AEmA, in close agreement with 43.8 % from
Peltier et al. Our number, however, rises to 53.7 % if we include
forms missing GlcN that, due to almost exactly correlated co-
elution, we judge to be produced within the electrospray source.
In-source decay also occurs with MALDI, but is harder to judge
without elution profiles. The most common trimer contains two
GlcN-MurNAc-AEm and one GlcN-MurNAc-AEmA, account-
ing for 30.7 % of all trimers (34.9 % including in-source decay)
and 42.7 % for Peltier et al. We did not find anhydrous MurNAc
as reported by Peltier et al., but rather anhydrousmDAP in the C-
terminal position (see spectra on page 18 of the Fig. S3 in ESM),
but this may be an in vitro water loss.
As shown in Fig. 2, we found at least one identification for
each distinct peak in the TIC elution profile. Byomap com-
putes a summed MS spectrum for each elution peak, and in
almost all cases, Fig. 2 lists the identification matching the
most intense peak in theMS spectrum. An exception is elution
peak 14, in which the most intense spectral peak has neutral
mass 1707.731 and remains unidentified. The MS spectra for
elution peaks 21 and 22 contain numerous low abundance
forms, most but not all of which match masses from
Tables 2 and 3.
Table 3 List of most abundant trimers with glycans, precursor masses, apex elution times and abundances
Peptides Charges Glycans Neutral
mass
Elution
time
XIC
integral
% of XICs
sum = 13.4 %
AEm, AEm, AEmA 2, 3, 4 GlcN-MurNAc, GlcN-MurNAc, GlcN-MurNAc 2520.096 34.76 7.03E + 09 4.12 %
3, 4 GlcN-MurNAc, MurNAc, GlcN-MurNAc 2359.027 34.84 9.39E + 08 0.55 %
AEm, AEmA, AEmA 2, 3, 4 GlcN-MurNAc, GlcN-MurNAc, GlcN-MurNAc 2591.133 35.77 4.48E + 09 2.63 %
AEm, AEm, AEmA 2, 3, 4 GlcN-MurNAc, GlcN-MurNAc 2081.911 31.87 1.50E + 09 0.88 %
AEm, AEm, AEmA 2, 3 GlcN-MurNAc, GlcN-MurNAc, GlcNAc-MurNAc 2562.107 36.79 1.38E + 09 0.81 %
AEm, AEm, AEmG 2, 3, 4 GlcN-MurNAc, GlcN-MurNAc, GlcN-MurNAc 2506.080 33.21 1.19E + 09 0.70 %
AEm, AEmA, AEmA 2, 3 GlcN-MurNAc, GlcN-MurNAc, GlcNAc-MurNAc 2633.144 37.54 1.14E + 09 0.67 %
AEmA, AEmA,
AEmA
3, 4 GlcN-MurNAc, GlcN-MurNAc, GlcN-MurNAc 2662.170 36.95 8.39E + 08 0.49 %
AEm, AEmA, AEmA 2, 3 GlcN-MurNAc, MurNAc, GlcN-MurNAc 2430.064 36.87 7.07E + 08 0.41 %
AEm, AEm, AEmA 3, 4 GlcNAc-MurNAc, GlcNAc-MurNAc, GlcNAc-
MurNAc
2646.138 35.69 5.05E + 08 0.30 %
AEm, AEmA, AEmG 3 GlcN-MurNAc, GlcN-MurNAc, GlcN-MurNAc 2577.117 34.00 4.77E + 08 0.28 %
AEmA, AEmA,
AEmG
3, 4 GlcNAc-MurNAc, MurNAc, GlcNAc-MurNAc 2571.107 40.13 3.88E + 08 0.23 %
AEm, AEmA, AEmG 3 GlcNAc-MurNAc, MurNAc, GlcNAc-MurNAc 2500.070 39.34 3.87E + 08 0.23 %
AEm, AEm, AEm 3, 4 GlcN-MurNAc, GlcN-MurNAc, GlcN-MurNAc 2449.059 33.68 3.45E + 08 0.20 %
AEm, AEm, AEmA 2, 3, 4 GlcN-MurNAc 1643.726 26.29 3.43E + 08 0.20 %
AEmA, AEmA,
AEmA
3 GlcN-MurNAc, GlcN-MurNAc, GlcNAc-MurNAc 2704.181 38.57 3.14E + 08 0.18 %
AEm, AEmA, AEmA 3, 4 GlcN-MurNAc, GlcN-MurNAc 2152.948 32.51 2.31E + 08 0.14 %
AEm, AEmA, AEmG 3 GlcN-MurNAc, GlcN-MurNAc, GlcNAc-MurNAc 2619.128 35.54 1.99E + 08 0.12 %
AEm, AEm, AEmG 3 GlcN-MurNAc, GlcNAc-MurNAc, GlcN-MurNAc 2548.091 34.46 1.82E + 08 0.11 %
AEm, AEm, AEmG 3 GlcN-MurNAc, MurNAc, GlcN-MurNAc 2345.012 33.21 1.54E + 08 0.09 %
35 % of the trimers correspond to a GlcN-MurNAc-AEm donors cross-linked to GlcN-MurNAc-AEmA acceptor stems via 3–3 bonds
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The most obvious departure from previous results is the
discovery of a number of peptide sequence variants, includ-
ing 5- and even 6-residue peptides, which have not been
reported before. Their presence in C. difficile is likely to be
due to the exchange activity of L,D-transpeptidases (Fig. S2
in the ESM), which has been demonstrated in vitro [12] for
several amino acids. These sequence variants are evidenced
by precursor masses matching within 5 ppm, in most cases
within 1 ppm, as well as high-quality fragmentation spec-
tra, one of which is shown Fig. 3 and others in Fig. S3 in
the ESM. The elution times of the monomers, with Arg,
Lys, His and Ser giving earlier elution times than Gly and
Ala, and Met, Val, Tyr, Lys and Phe giving later elution
times, matches measurements made for peptide elution time
predictors [13]. It is tempting to assume that such uncon-
ventional muropeptides are present in other bacterial pepti-
doglycans but have not been reported so far due to their
low abundance. Both high MS sensitivity and automated
MS/MS spectrum analysis will be required to test if similar
unconventional muropeptides are found in other PG.
It is worth noting that our nano-LC strategy uses only
300 ng of PG material, about 30 times less material than a
recently published Bhighly sensitive^ UPLC strategy [6].
The relatively short run time (about 50 min) is much faster
than traditional offline fractionation (140 min for C. difficile),
and comparable to the UPLC strategy [6], which employs no
mass spectrometry and is hence more suited to comparison
than to discovery. Nano-LC-ESI-MS/MS thus appears to be
the most effect data acquisition strategy yet devised for PG
structural analyses.
Complementing the data acquisition strategy, our bioinfor-
matics search strategy gives high sensitivity and acceptably
low false-positive rate, even for trimers for which almost 2/3
of the fragment peak predictions are incorrect. The primary
reason for the low error rate is the simplicity of the search
relative to other glycoproteomics searches. The trimer search
a 
b 
Fig. 2 (a) Total ion
chromatogram shows PG
components ordered by
hydrophobicity, monomers
generally eluting before dimers
and trimers. (b) Major component
for each elution peak. Most peaks
also contain several minor
components. Peaks 11 and 12 and
also 16 and 17, contain isomers,
possibly epimers,
indistinguishable by precursor
mass and MS/MS scans
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ab 
Fig. 4 (a) HCD and (b) ETD
spectra of a dimer with that could
be either GlcN-MurNAc-A-E-
mDAP 3–3 linked to GlcN-
MurNAc-A-E-mDAP-A-A or
GlcN-MurNAc-A-E-mDAP-A
4–3 linked to GlcN-MurNAc-A-
E-mDAP-A. The HCD spectrum
contains no peaks (such as an A-
A y-ion for 3–3) that can distin-
guish the two possibilities, but the
ETD spectrum contains peaks at
899.45 and 884.42 matching the
theoretical masses (given on the
fragmentation diagram) of 899.32
and 884.39 for c- and z-ions
splitting donor and acceptor
peptides. The ETD spectrum
therefore shows that the dimer is
4–3 linked. Byonic gives a
fragmentation diagram and
annotates c2, y2, y3, z2 and z3 for
[+438]AEM[+41][+881]A
crosslinked to [+438]AEM[+
41]A, where [+438] represents
the disaccharide, M[+41]
represents mDAP, and [+881] the
cross-link Bmodification^ onM[+
41], but Byonic does not annotate
internal fragments nor the
disambiguating peaks at 899.45
and 884.42
Fig. 3 Collisional dissociation
(HCD) spectrum of an
unanticipated sequence variant,
recognized by high-accuracy
(5 ppm precursor and 20 ppm
fragment) mass spectrometry.
Other fourth residue variants
include: Phe, Ile/Leu, Ser, Met,
Val, Arg, Lys and His. The small
peptide fragmentation diagram on
the right side of the tandem mass
spectrum shows Byonic’s
automatic assignment of spectrum
peaks
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includes about 2 × 2 × 20 peptide sequences (two possibilities
for each donor peptide and up to 20 for the terminal acceptor
peptide) and 5 × 5 × 5 possibilities for glycosylation (no gly-
can, MurNAc, GlcN-MurN, GlcN-MurNAc and GlcNAc-
MurNAc), for a total of about ∼5000 candidates with less than
500 distinct masses. Accurate precursor mass alone, without
fragmentation, can resolve almost all precursors in a Bsearch
space^ of this size; for example, GlcNAc-MurNAc-AEmA
and GlcN-MurNAc-AEM(I/L) differ by 38 ppm, almost 8
times the precursor mass tolerance of 5 ppm.We also find that
our search strategy gave acceptably low false-negative rate:
All the TIC elution peaks in Fig. 2 have identifications, and in
all but a few cases mentioned above, these identifications
explain the major peaks in the summed MS spectra.
As mentioned above, we relied on manual analysis to dis-
tinguish 3–3 from 4–3 cross-links, so we limited attention to
the most abundant dimers. All the MS/MS spectra we exam-
ined of precursors with mass matching 2 × GlcN-MurNAc-
AEmA appeared to contain 4–3 cross-links, rather than a 3–
3 link between GlcN-MurNAc-AEm and GlcN-MurNAc-
AEmAA. This finding is of course unsurprising because it
agrees with monomer abundances. The sample may, however,
contain some amount of the 3–3 form co-eluting with the 4–3
form. Figure 4 gives an example manual analysis for both
HCD and ETD spectra. The HCD spectrum contains no peaks
distinguishing 3–3 and 4–3 cross-links, partly because HCD
spectra of PG components are dominated by internal frag-
ments, few of which can be unambiguously linked to one
cross-link form. For example, an internal fragment with the
mass of two mDAP residues would be unambiguous evidence
of a 3–3 link, but an internal fragment with the mass equal to
the sum of one Ala and two mDAP residues could arise from
either cross-link form. ETD spectra, however, are much sim-
pler, dominated by c- and z-ions, and we found that ETD
spectra of PG dimers generally include strong peaks such as
899.45 and 884.42 in Fig. 4 for the c- and z-ions splitting the
monomers. We find that ETD, which to our knowledge has
not been applied to PG analysis before, offers a promising
alternative or adjunct to collisional fragmentation.
All the MS/MS spectra we examined of dimers containing
GlcN-MurNAc-AEm and GlcN-MurNAc-AEmA appeared to
contain 3–3 cross-links. Figure 5 gives a manually annotated
spectrum. Notice that in both Figs. 4 and 5, the ETD spectra
show strong cleavage at the glycosidic bonds between GlcN
and MurNAc (thereby localizing the deacetylation), between
MurNAc and the lactyl group, and between the lactyl group
and the alanine residue in position 1; this cleavage pattern is
somewhat unexpected because ETD generally cleaves peptide
bonds more readily than glycosidic bonds [14]. Also notice that
in Fig. 4, the cleavage between mDAP and D-Ala shows a hy-
drogen transfer from the c-ion to the z-ion, a common occurrence
in ETD spectra of peptides with precursor charge z = 2+ [15].
As shown in Figure S1 in the ESM, the 4–3 dimer shows
two distinct elution peaks at 30.6 and 32.2 min, with the ear-
lier peak about twice as abundant as the later. The 3–3 dimer
has distinct peaks at 28.6 and 31 min in the ratio of about 4:1.
In both cases, the MS/MS spectra show no differences be-
tween the two elution peaks. We speculate as others have
before [11, 16] that these dimers have two forms each, differ-
ing only in stereochemistry.
Fig. 5 ETD spectrum of GlcN-
MurNAc-A-E-mDAP 3–3 linked
to GlcN-MurNAc-A-E-mDAP-
A. The peaks at 828.45 and
884.42 match the theoretical
masses of 828.38 and 884.39 for
c- and z-ions splitting donor and
acceptor peptides. ETD fragments
PG components at both peptide
and glycosidic bonds, including
the C–O bond between the lactyl
group and MurNAc, shown in the
fragmentation diagram with a line
across MurNAc
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Conclusion
This study describes an effective data-dependent tandemmass
spectrum acquisition strategy, along with an almost fully au-
tomated data analysis approach to identify muropeptide struc-
tures, employing C. difficile PG as a proof of concept. We
showed that nano-LC separation combined with the low
ppm m/z accuracy of the Orbitrap mass spectrometer allows
the structural analysis of sub-microgram amounts of peptido-
glycan extracted from the equivalent of as few as 104 cells in
less than an hour. The objective automated analysis ofMS/MS
spectra by the Byonic software confirmed previous structural
analyses and revealed several modifications found in low
abundance that had not been reported so far in C. difficile, in
particular a wide variety of C-terminal amino acids in acceptor
peptides. Taken together, we propose that this novel analysis
pipeline could replace the conventional chromatographic and
mass spectrometric approaches used for the past 30 years.
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